Risk of Bronchospasm and Coronary Arteriospasm With Sugammadex Use: A Post Marketing Analysis
Therapeutic Advances in Drug Safety - United Kingdom
doi 10.1177/2042098619869077
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 1, 2019
Authors
Publisher
SAGE Publications